These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 9430847

  • 1. Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells.
    Quaschning T, Königer M, Krämer-Guth A, Greiber S, Pavenstädt H, Nauck M, Schollmeyer P, Wanner C.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2528-36. PubMed ID: 9430847
    [Abstract] [Full Text] [Related]

  • 2. VLDL and LDL metabolism in human and rat mesangial cells.
    Krämer-Guth A, Nauck M, Quaschning T, Pavenstädt H, Wieland H, Schollmeyer P, Wanner C.
    Nephron; 1996 Dec; 74(2):378-85. PubMed ID: 8893159
    [Abstract] [Full Text] [Related]

  • 3. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts.
    Gianturco SH, Brown FB, Gotto AM, Bradley WA.
    J Lipid Res; 1982 Sep; 23(7):984-93. PubMed ID: 6292317
    [Abstract] [Full Text] [Related]

  • 4. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
    Li J, Li H, Wen YB, Li XW.
    Nephron Physiol; 2008 Sep; 110(1):p1-10. PubMed ID: 18698144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells.
    Krämer A, Nauck M, Pavenstädt H, Schwedler S, Wieland H, Schollmeyer P, Wanner C.
    Kidney Int; 1993 Dec; 44(6):1341-51. PubMed ID: 8301935
    [Abstract] [Full Text] [Related]

  • 7. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
    Dashti N, Wolfbauer G.
    Biochim Biophys Acta; 1986 Feb 28; 875(3):473-86. PubMed ID: 3004589
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Nov 15; 98(10):2259-67. PubMed ID: 8941642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
    Krämer-Guth A, Nauck M, Pavenstädt H, Königer M, Wieland H, Schollmeyer P, Wanner C.
    J Am Soc Nephrol; 1994 Oct 15; 5(4):1081-90. PubMed ID: 7849247
    [Abstract] [Full Text] [Related]

  • 16. Cellular mechanisms of lipid injury in the glomerulus.
    Schlondorff D.
    Am J Kidney Dis; 1993 Jul 15; 22(1):72-82. PubMed ID: 8322798
    [Abstract] [Full Text] [Related]

  • 17. Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro.
    Chappell DA, Fry GL, Waknitz MA, Muhonen LE, Pladet MW.
    J Biol Chem; 1993 Dec 05; 268(34):25487-93. PubMed ID: 8244984
    [Abstract] [Full Text] [Related]

  • 18. The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2.
    Mulder M, de Wit E, Havekes LM.
    Biochim Biophys Acta; 1991 Feb 05; 1081(3):308-14. PubMed ID: 1847834
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.